In vivo PET imaging with [18F]FDG to explain improved glucose uptake in an apolipoprotein A-I treated mouse model of diabetes
dc.contributor.author | Cochran, BJ | en_AU |
dc.contributor.author | Ryder, WJ | en_AU |
dc.contributor.author | Parmar, A | en_AU |
dc.contributor.author | Tang, S | en_AU |
dc.contributor.author | Reilhac, A | en_AU |
dc.contributor.author | Arthur, A | en_AU |
dc.contributor.author | Charil, A | en_AU |
dc.contributor.author | Hamze, H | en_AU |
dc.contributor.author | Barter, PJ | en_AU |
dc.contributor.author | Kritharides, L | en_AU |
dc.contributor.author | Meikle, SR | en_AU |
dc.contributor.author | Grégoire, MC | en_AU |
dc.contributor.author | Rye, KA | en_AU |
dc.date.accessioned | 2018-09-14T04:44:39Z | en_AU |
dc.date.available | 2018-09-14T04:44:39Z | en_AU |
dc.date.issued | 2016-05-18 | en_AU |
dc.date.statistics | 2018-09-10 | en_AU |
dc.description.abstract | Type 2 diabetes is characterised by decreased HDL levels, as well as the level of apolipoprotein A-I (apoA-I), the main apolipoprotein of HDLs. Pharmacological elevation of HDL and apoA-I levels is associated with improved glycaemic control in patients with type 2 diabetes. This is partly due to improved glucose uptake in skeletal muscle.© 2016 Springer Nature | en_AU |
dc.identifier.citation | Cochran, B. J., Ryder, W. J., Parmar, A., Tang, S., Reilhac, A., Arthur, A., Charil, A., Hamze, H., Barter, P. J., Kritharides, L. Meikle, S. R., Grégoire, M. C. & Rye, K. (2016). In vivo PET imaging with [18F] FDG to explain improved glucose uptake in an apolipoprotein AI treated mouse model of diabetes. Diabetologia, 59(9), 1977-1984. doi:10.1007/s00125-016-3993-5 | en_AU |
dc.identifier.govdoc | 8698 | en_AU |
dc.identifier.issn | 1432-0428 | en_AU |
dc.identifier.issue | 9 | en_AU |
dc.identifier.journaltitle | Diabetologia | en_AU |
dc.identifier.pagination | 1977-1984 | en_AU |
dc.identifier.uri | https://doi.org/10.1007/s00125-016-3993-5 | en_AU |
dc.identifier.uri | http://apo.ansto.gov.au/dspace/handle/10238/8986 | en_AU |
dc.identifier.volume | 59 | en_AU |
dc.language.iso | en | en_AU |
dc.publisher | Springer Nature | en_AU |
dc.subject | Diabetes mellitus | en_AU |
dc.subject | Fluorodeoxyglucose | en_AU |
dc.subject | Insulin | en_AU |
dc.subject | Kinetics | en_AU |
dc.subject | Positron computed tomography | en_AU |
dc.subject | Simulation | en_AU |
dc.subject | Lipoproteins | en_AU |
dc.subject | Radiopharmaceuticals | en_AU |
dc.subject | Phosphorylation | en_AU |
dc.title | In vivo PET imaging with [18F]FDG to explain improved glucose uptake in an apolipoprotein A-I treated mouse model of diabetes | en_AU |
dc.type | Journal Article | en_AU |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: